D-0660-2026 Class II Ongoing

Recalled by Lannett Company Inc. — Seymour, IN

FDA drug recall D-0660-2026 was initiated by Lannett Company Inc. on Jun 26, 2026 and is designated Class II. Reason for recall: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. The recall status is ongoing. Affected quantity: 1392 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2026
Initiation Date
Jun 26, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1392 bottles

Product description

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.

Reason for recall

Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

Distribution pattern

US Nationwide.

Code information

Lot#: 25285401A, Exp. Date: 04/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0660-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0660-2026. Report a data issue: hello@regdatalab.com.